A.R.T. Advisors’s Biocept, Inc. BIOC Stock Holding History

A.R.T. Advisors’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-83	Closed	-$18K	–	288
2020 Q2	$18K	Buy	+83	New	+$11.9K	0.03%	264
2019 Q4	–	Sell	-100	Closed	-$24K	–	1831
2019 Q3	$24K	Buy	+100	New	+$28.8K	﹤0.01%	1360

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

A.R.T. Advisors's BIOC Position: Q3 2020 in Review

A.R.T. Advisors sold out of Biocept, Inc. (BIOC) in Q3 2020, closing a stake of 83 shares — an estimated $18K sold.

A.R.T. Advisors first reported a position in BIOC in Q3 2019 and held it in 2 quarters. The position peaked at $24K in Q3 2019. 18 funds tracked by Wall St. Rank hold BIOC as of Q3 2020.

A.R.T. Advisors reported no remaining Biocept, Inc. position as of Q3 2020 after selling out during the quarter.
A.R.T. Advisors sold 83 Biocept, Inc. shares in Q3 2020, an estimated $18K.
A.R.T. Advisors first reported a position in Biocept, Inc. in Q3 2019 and held it in 2 quarters.
A.R.T. Advisors's Biocept, Inc. position peaked at $24K in Q3 2019.
18 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2020.

Based on A.R.T. Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.